ArticleEuropean journal of neurology2022

A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome'.

Francesco Patti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.